Sinovac regimen gets strong boost from Pfizer, AstraZeneca or J&J COVID shots - study

  • 📰 ReutersScience
  • ⏱ Reading Time:
  • 12 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 51%

United States Headlines News

United States Latest News,United States Headlines

A third booster dose of a COVID-19 vaccine made by AstraZeneca, Pfizer-BioNTech or Johnson & Johnson increases antibody levels significantly in those who have previously received two doses of Sinovac's CoronaVac shot, a study has found.

Vials of Chinese Sinovac's CoronaVac vaccine against coronavirus disease pictured inside the newly inaugurated production lab designated to manufacture the vaccine, in Constantine, Algeria September 29, 2021.

However, another study in December found that Sinovac's two-dose shot followed by a booster dose of Pfizer-BioNTech's vaccine showed a lower immune response against the Omicron variant compared with other strains.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Any chance we will have vaccines in future which provide antibodies for like years

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 559. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.